Literature DB >> 15987267

Modification of epileptiform discharges in neocortical neurons following glutamate uptake inhibition.

Susan Campbell1, John J Hablitz.   

Abstract

Sodium-dependent high-affinity glutamate transporters regulate synaptic glutamate levels to maintain low ambient levels of glutamate and prevent excitotoxicity. Most studies using pharmacological inhibition of glutamate transport to examine the involvement of glutamate transporters in regulating synaptic activity have examined small synaptic currents. Using in vitro brain slices, we investigated the effects of uptake inhibition on two types of epileptiform activity, bicuculline-induced paroxysmal activity, and epileptiform responses in the freeze-lesion epilepsy model. In layer II/III pyramidal cells of the prefrontal cortex, inhibiting uptake with low concentrations of DL-threo-ss-benzyloxyaspartic acid (TBOA) (20 or 30 microM) prolonged bicuculline-induced epileptiform activity. At higher concentrations, TBOA (150 or 300 microM) caused a transient enhancement of epileptiform discharges that was followed by a decrease. In the freeze-lesion model, inhibiting uptake also increased the amplitude and response area of evoked activity. The prolongation of epileptiform activity exhibited by the inhibition of glutamate uptake (TBOA 20 or 30 microM) is attributed to an increase in the level of glutamate extracellularly during uptake blockade, resulting in sustained activation of glutamate receptors. The decrease in epileptiform activity at higher TBOA concentration could be due to glutamate receptor desensitization or loss of excitability due to a depolarization block. The present results suggest that decreases in glutamate uptake can be proconvulsant in the two models of epilepsy examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987267     DOI: 10.1111/j.1528-1167.2005.01020.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

1.  Genetic deletion of the neuronal glutamate transporter, EAAC1, results in decreased neuronal death after pilocarpine-induced status epilepticus.

Authors:  Meredith C Lane; Joshua G Jackson; Elizabeth N Krizman; Jeffery D Rothstein; Brenda E Porter; Michael B Robinson
Journal:  Neurochem Int       Date:  2013-12-12       Impact factor: 3.921

2.  Glutamate biosensor imaging reveals dysregulation of glutamatergic pathways in a model of developmental cortical malformation.

Authors:  C G Dulla; H Tani; J Brill; R J Reimer; J R Huguenard
Journal:  Neurobiol Dis       Date:  2012-09-11       Impact factor: 5.996

Review 3.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

4.  Extrasynaptic glutamate receptor activation as cellular bases for dynamic range compression in pyramidal neurons.

Authors:  Katerina D Oikonomou; Shaina M Short; Matthew T Rich; Srdjan D Antic
Journal:  Front Physiol       Date:  2012-08-24       Impact factor: 4.566

5.  Functional changes in glutamate transporters and astrocyte biophysical properties in a rodent model of focal cortical dysplasia.

Authors:  Susan L Campbell; John J Hablitz; Michelle L Olsen
Journal:  Front Cell Neurosci       Date:  2014-12-17       Impact factor: 5.505

6.  Astroglial Cx30 sustains neuronal population bursts independently of gap-junction mediated biochemical coupling.

Authors:  Ulrike Pannasch; Elena Dossi; Pascal Ezan; Nathalie Rouach
Journal:  Glia       Date:  2019-02-22       Impact factor: 7.452

7.  Laser-scanning astrocyte mapping reveals increased glutamate-responsive domain size and disrupted maturation of glutamate uptake following neonatal cortical freeze-lesion.

Authors:  Moritz Armbruster; David Hampton; Yongjie Yang; Chris G Dulla
Journal:  Front Cell Neurosci       Date:  2014-09-09       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.